Pharmacology

Action Mechanism of Action Reference
INHIBITOR ErbB-2/ErbB-3 heterodimer inhibitor

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Carcinoma, Non-Small-Cell Lung 4 D002289 FDA
Pancreatic Neoplasms 4 D010190 FDA
Breast Neoplasms 2 D001943 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4298025
FDA SRS AE72RB1W1X